Skip to main content
. 2022 Apr 24;12(5):1064. doi: 10.3390/diagnostics12051064

Table 3.

Description of studies using different radiomics featured to determine the histologic subtype classification of lung cancer.

Year References Number of Cases Imaging Modality Group a Validation * Combined Model b Diagnostic Performance
2018 Xinzhong Zhu [67] 129 CT SPN Yes (internal) No AUC = 0.905 (ADC vs. SCC)
2021 Yong Han [76] 1419 CT SPN Yes (internal) No AUC = 0.903
2021 Huanhuan Li [73] 200 CT SPN Yes (internal) No AUC = 0.879 (ADC vs. SCC), 0.836 (ADC vs. SCLC), 0.783 (SCC vs. SCLC)
2019 Linning E [68] 229 CT SPN No No AUC = 0.801 (ADC vs. SCC), 0.857 (ADC vs. SCLC), 0.657 (SCC vs. SCLC)
2021 Yixian Guo [75] 920 CT SPN Yes (internal) No AUC = 0.84 (Accuracy = 71.6%)
2021 Fengchang Yang [77] 324 CT SPN Yes (internal) No AUC = 0.78
2021 Zahra Khodabakhshi [74] 354 CT SPN No No AUC = 0.747 (Accuracy = 86.5%)
2019 Linning E [71] 278 CT SPN No No AUC = 0.741 (SCLC vs. NSCLC)
2020 Charlems Alvarez-Jimenez [65] 171 CT SPN Yes (external) No AUC = 0.72 (ADC vs. SCC)
2019 Jian Liu [70] 349 CT SPN Yes (internal) No Accuracy = 89%
2021 Yan lei Ji [72] 253 CT SPN Yes (internal) Yes AUC = 0.982 (ADC vs. SCC)
2021 Jianyuan ZHOU [78] 182 PET-CT SPN Yes (internal) Yes AUC = 0.862 (Sensitivity = 88%, Specificity = 72.73%, ADC vs. SCC)
2019 Xue Sha [69] 100 PET-CT SPN Yes (internal) Yes AUC = 0.781 (Sensitivity = 100%, Specificity = 70%, ADC vs. SCC)
2016 Weimiao Wu [66] 350 CT SPN Yes (internal) Yes AUC = 0.72 (ADC vs. SCC)

ADC: adenocarcinoma; SCLC: small cell lung cancer; NSCLC: non-small cell lung cancer; SCC: squamous cell carcinoma. a Group: refers to the type of lung nodules analyzed in this study. b Combined model: refers to whether the model has clinical or semantic information added to it. * Internal stands for internal validation; external stands for external validation. Internal validation was defined as a prediction method drawn from a similar population as the original training cohort; external validation is the action of testing the developed prediction model in a set of the population independent of the original training cohort.